about
StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.New therapies for dedifferentiated papillary thyroid cancerAssociation between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancerProfiling of ileal carcinoids.Thyroid dysfunctions induced by tyrosine kinase inhibitors.Advances in thyroid cancer treatment: latest evidence and clinical potential.Selective use of vandetanib in the treatment of thyroid cancer.CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib.Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.Novel therapeutic clues in thyroid carcinomas: The role of targeting cancer stem cells.Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.Sorafenib in the treatment of thyroid cancer.Molecular testing in the diagnosis of differentiated thyroid carcinomas
P2860
Q33679597-27C1C091-71BF-45EF-B27C-6696A560483FQ33782114-580BBF97-32D7-45B5-8F5C-0AD2C46EDB01Q35381593-E65639E5-41A2-43B6-A763-F859EA0EE10AQ35908104-D34F717E-972F-4CAC-B69D-452A8C2FD874Q38044219-1FA357AD-0D31-4331-81D9-C2E768BDD2BFQ38211342-28D331E3-5729-45D1-B60F-31A81DB81985Q38305056-B6D952FD-8811-4CF6-ACC9-181C421FE6BEQ38546474-DA9A446B-68AF-4204-AED8-8A84430372E6Q38842666-747C4B95-78FB-4C3C-9858-64AAD901DEF8Q38960074-090E11B5-BB5B-4D2B-876E-70B13406479DQ39017645-21074CF5-215C-401F-A80A-C5C201D4BF59Q39167915-83EB1BBD-0A74-4014-BC3C-4C097843B08CQ39354316-711C570B-D685-43C3-A592-EE2DA7CFBFD6Q40479779-EA6CD2BB-6EA7-488B-82BE-372602DD60CDQ41251561-354A7A6A-A67F-41AD-9A36-C6359492AAC8Q53644218-4053746B-7AD2-46E3-8A7F-DBD70E5D62DEQ55053748-C68D388C-6CC6-49F3-97A3-CCD958EA19D7Q58805430-A391E472-6331-4828-806B-3B36E9D4F6EC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
RET TKI: potential role in thyroid cancers.
@en
RET TKI: potential role in thyroid cancers.
@nl
type
label
RET TKI: potential role in thyroid cancers.
@en
RET TKI: potential role in thyroid cancers.
@nl
prefLabel
RET TKI: potential role in thyroid cancers.
@en
RET TKI: potential role in thyroid cancers.
@nl
P2093
P2860
P1476
RET TKI: potential role in thyroid cancers
@en
P2093
Alessandro Antonelli
Caterina Mancusi
Clodoveo Ferri
Poupak Fallahi
Silvia Martina Ferrari
P2860
P2888
P304
P356
10.1007/S11912-012-0217-0
P577
2012-04-01T00:00:00Z